Established in 2005 by entrepreneur Daphne Zohar, PureTech Health is a biotechnology organisation which produces drugs to battle fatal infections. The organisation is focused on developing logical and specialised experiences which are at a significant intonation point, including the nervous system, gastrointestinal and immunity, and the communications and motioning between them. The organisation has a powerful line-up of cutting-edge programmes that are zeroed in on tending to a portion of the people’s medical service’s needs. It is recorded on the London Stock Exchange and is on the FTSE 250 Index.
The company is engaged in research, creating and commercialising prescriptions for illnesses, including obstinate malignant growths, lymphatic and gastrointestinal infections, nervous system problems, and immunological sicknesses, among others. The company’s fragments incorporate Internal and Affiliates. The Internal division is centred around propelling a pipeline filled by revelations in lymphatics and safe cell dealing to tweak infection in a tissue-explicit way.
The Affiliates division is involved the projects within the division that are merged operational auxiliaries that have innovative work programmes. It is wholly owned pipeline incorporates different candidates, like LYT-100, LYT-200, LYT-210, Lymphatic Targeting Chemistry Platform, Milk Exosome Platform, and Meningeal Lymphatics Platform.
The organisations which together to form PureTech Health were Karuna Pharmaceuticals, Gelesis, which has got FDA endorsement for weight management treatment, Akili Interactive Labs, which is fostering a computerised remedial stage for intellectual disorders, Vedanta Biosciences, which is creating medications to treat immune system and provocative diseases, and Follica, which is growing new medicines for androgenetic alopecia, among others.
PureTech additionally has its very own pipeline immunology, lymphatic, and oncology-based therapeutics. Puretech likewise creates innovation and items for screening, determination, and treatment of neurological problems like ADHD, mental imbalance, and sorrow through PC programming; non-invasive neurostimulation treatment for mental issues; and mix treatment for schizophrenia. The organisation offers key trials and de-risking programmes for creating and dispatching new therapeutics.
PureTech Health PLC 501 Boylston St Ste 6102 BOSTON, MA 02116-3769 United States